Search Results - "Rehak, Matus"

Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study by Theilig, Theresa, Rehak, Matus, Busch, Catharina, Bormann, Caroline, Schargus, Marc, Unterlauft, Jan Darius

“…The aim of this study was to compare the efficacy and safety profile of XEN microstent implantation with trabeculectomy (TET) in a comparable group of…”
Get full text

Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities by Rehak, Jiri, Rehak, Matus

“…In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein compression, degenerative changes of the vessel wall and abnormal…”
Get full text

The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015 by Alfaar, Ahmad Samir, Saad, Anas, Wiedemann, Peter, Rehak, Matus

“…Purpose To calculate the overall incidence of uveal melanoma in Germany and to compare incidences in different German states. In addition, we computed the…”
Get full text

Degenerative lamellar macular holes: tractional development and morphological alterations by Bringmann, Andreas, Unterlauft, Jan Darius, Wiedemann, Renate, Barth, Thomas, Rehak, Matus, Wiedemann, Peter

“…Purpose The development of degenerative lamellar macular holes (DLH) is largely unclear. This study was aimed at documenting with spectral-domain optical…”
Get full text

Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro by Deissler, Heidrun L., Busch, Catharina, Wolf, Armin, Rehak, Matus

“…Because rare, but severe adverse effects, i.e. retinal vasculitis or retinal vein occlusion, have been observed after repetitive intravitreal injections of…”
Get full text

Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment by Rehak, Matus, Busch, Catharina, Unterlauft, Jan-Darius, Jochmann, Claudia, Wiedemann, Peter

“…Aims Fluocinolone acetonide (FAc) is an intravitreal corticosteroid implant approved for the second-line treatment of diabetic macular edema (DME). This study…”
Get full text

Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case Series by Girbardt, Christian, Busch, Catharina, Al-Sheikh, Mayss, Gunzinger, Jeanne Martine, Invernizzi, Alessandro, Xhepa, Alba, Unterlauft, Jan Darius, Rehak, Matus

“…Background: To describe cases of retinal vascular events shortly after administration of mRNA or adenoviral-vectored COVID-19 vaccines. Design: Retrospective,…”
Get full text

Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma by Schargus, Marc, Theilig, Theresa, Rehak, Matus, Busch, Catharina, Bormann, Caroline, Unterlauft, Jan Darius

“…The aim of this retrospective study was to compare the efficacy and safety profile of a single XEN-microstent in different types of primary and secondary open…”
Get full text

GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study by Rodríguez-Valdés, Patricio J., Rehak, Matus, Zur, Dinah, Sala-Puigdollers, Anna, Fraser-Bell, Samantha, Lupidi, Marco, Chhablani, Jay, Cebeci, Zafer, Laíns, Inês, Chaikitmongkol, Voraporn, Fung, Adrian T., Okada, Mali, Unterlauft, Jan Darius, Smadar, Lital, Loewenstein, Anat, Iglicki, Matias, Busch, Catharina

“…To analyze functional and anatomical response patterns to dexamethasone (DEX) implant in diabetic macular edema (DME), to describe proportion of responders and…”
Get full text

Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial by Seibel, Ira, Vollhardt, Daniela, Riechardt, Aline I., Rehak, Matus, Schmied, Sabine, Schiller, Petra, Zeitz, Oliver, Hellmich, Martin, Joussen, Antonia M.

“…Purpose To demonstrate superiority of intravitreal ranibizumab 0.5 mg compared to focal and peripheral laser treatment in patients with radiation retinopathy…”
Get full text

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema by Busch, Catharina, Zur, Dinah, Fraser-Bell, Samantha, Laíns, Inês, Santos, Ana Rita, Lupidi, Marco, Cagini, Carlo, Gabrielle, Pierre-Henry, Couturier, Aude, Mané-Tauty, Valérie, Giancipoli, Ermete, Ricci, Giuseppe D’Amico, Cebeci, Zafer, Rodríguez-Valdés, Patricio J., Chaikitmongkol, Voraporn, Amphornphruet, Atchara, Hindi, Isaac, Agrawal, Kushal, Chhablani, Jay, Loewenstein, Anat, Iglicki, Matias, Rehak, Matus

“…Aims To compare functional and anatomical outcomes of continued anti-vascular endothelial growth factor (VEGF) therapy versus dexamethasone (DEX) implant in…”
Get full text

Morphology of partial-thickness macular defects: presumed roles of Müller cells and tissue layer interfaces of low mechanical stability by Bringmann, Andreas, Unterlauft, Jan Darius, Wiedemann, Renate, Rehak, Matus, Wiedemann, Peter

“…The pathogenesis of partial-thickness macular defects and the role of Müller glial cells in the development of such defects are not well understood. We…”
Get full text

General health of patients with diabetic macular edema-The LIPSIA study by Busch, Catharina, Katzmann, Julius L, Jochmann, Claudia, Unterlauft, Jan Darius, Vollhardt, Daniela, Wiedemann, Peter, Laufs, Ulrich, Rehak, Matus

“…Cardiovascular risk factors such as hypertension or dyslipidemia can influence the incidence and progression of diabetic retinopathy (DR) and diabetic macular…”
Get full text

Analyzing the impact of glaucoma on the macular architecture using spectral-domain optical coherence tomography by Unterlauft, Jan D, Rehak, Matus, Böhm, Michael R R, Rauscher, Franziska G

“…Using spectral domain optical coherence tomography (SD-OCT) the retina can be segmented automatically to visualize all retinal layers. In glaucoma chronically…”
Get full text

Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B) by Hattenbach, Lars‐Olof, Feltgen, Nicolas, Bertelmann, Thomas, Schmitz‐Valckenberg, Steffen, Berk, Hüsnü, Eter, Nicole, Lang, Gabriele E., Rehak, Matus, Taylor, Simon R., Wolf, Armin, Weiss, Claudia, Paulus, Eva‐Maria, Pielen, Amelie, Hoerauf, Hans

“…Purpose To compare the efficacy and safety of ranibizumab 0.5 mg versus dexamethasone 0.7 mg according to their European labels in macular oedema secondary to…”
Get full text

Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A165 No Longer Depends on the Growth Factor’s Presence by Deissler, Heidrun L., Rehak, Matus, Wolf, Armin

“…As responses of immortalized endothelial cells of the bovine retina (iBREC) to VEGF-A165 depend on exposure time to the growth factor, we investigated changes…”
Get full text

Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers by Veelken, Rhea, Maiwald, Bettina, Strocka, Steffen, Petersen, Tim-Ole, Moche, Michael, Ebel, Sebastian, Denecke, Timm, Rehak, Matus, Struck, Manuel Florian, Forstmeyer, Dirk, Rademacher, Sebastian, Seehofer, Daniel, Berg, Thomas, van Bömmel, Florian

“…Chemosaturation (CS; CHEMOSAT®, Delcath Systems Inc.) temporarily administers melphalan into the liver by percutaneous hepatic perfusion (PHP). CS-PHP can…”
Get full text

Different modes of foveal regeneration after closure of full-thickness macular holes by (re)vitrectomy and autologous platelet concentrate by Bringmann, Andreas, Jochmann, Claudia, Unterlauft, Jan Darius, Wiedemann, Renate, Rehak, Matus, Wiedemann, Peter

“…To describe using spectral-domain optical coherence tomography the regeneration of the foveal morphology after pars plana (re)vitrectomy surgery and gas…”
Get full text

Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1‐year results of the COMRADE extension study by Feltgen, Nicolas, Hattenbach, Lars‐Olof, Bertelmann, Thomas, Callizo, Josep, Rehak, Matus, Wolf, Armin, Berk, Hüsnü, Eter, Nicole, Lang, Gabriele E., Pielen, Amelie, Schmitz‐Valckenberg, Steffen, Quiering, Claudia, Rose, Uwe, Hoerauf, Hans

“…Purpose The COMRADE studies are the first randomized controlled head‐to‐head trials comparing the efficacy and safety of intravitreal ranibizumab versus…”
Get full text

Macular cystic changes as predictive factor for the recurrence of macular oedema in branch retinal vein occlusion by Tilgner, Eric, Dalcegio Favretto, Maiara, Tuisl, Maria, Wiedemann, Peter, Rehak, Matus

“…Aim To evaluate the role of small cystic macular changes as a prognostic factor for the recurrence of macular oedema (ME) in patients with branch retinal vein…”
Get full text